NO942707D0 - Syntetiske peptider egnet for vaksine mot rubellsinfeksjoner - Google Patents

Syntetiske peptider egnet for vaksine mot rubellsinfeksjoner

Info

Publication number
NO942707D0
NO942707D0 NO942707A NO942707A NO942707D0 NO 942707 D0 NO942707 D0 NO 942707D0 NO 942707 A NO942707 A NO 942707A NO 942707 A NO942707 A NO 942707A NO 942707 D0 NO942707 D0 NO 942707D0
Authority
NO
Norway
Prior art keywords
synthetic peptides
peptides suitable
vaccine
rubella infections
rubella
Prior art date
Application number
NO942707A
Other languages
English (en)
Other versions
NO942707L (no
Inventor
Pele Chong
Shirley Gillam
Dawei Ou
Aubrey Tingle
Original Assignee
Connaught Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connaught Lab filed Critical Connaught Lab
Publication of NO942707D0 publication Critical patent/NO942707D0/no
Publication of NO942707L publication Critical patent/NO942707L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36211—Rubivirus, e.g. rubella virus
    • C12N2770/36222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO942707A 1992-01-20 1994-07-19 Syntetiske peptider egnet for vaksine mot rubellsinfeksjoner NO942707L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929201139A GB9201139D0 (en) 1992-01-20 1992-01-20 Synthetic peptides for a rubella vaccine
PCT/CA1993/000014 WO1993014206A2 (en) 1992-01-20 1993-01-20 Synthetic peptides for a rubella vaccine

Publications (2)

Publication Number Publication Date
NO942707D0 true NO942707D0 (no) 1994-07-19
NO942707L NO942707L (no) 1994-09-20

Family

ID=10708876

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942707A NO942707L (no) 1992-01-20 1994-07-19 Syntetiske peptider egnet for vaksine mot rubellsinfeksjoner

Country Status (10)

Country Link
US (1) US6037448A (no)
EP (1) EP0624198A1 (no)
JP (1) JPH07503133A (no)
AU (1) AU662954B2 (no)
CA (1) CA2128407C (no)
FI (1) FI943418A (no)
GB (1) GB9201139D0 (no)
NO (1) NO942707L (no)
RU (1) RU94040393A (no)
WO (1) WO1993014206A2 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5427792A (en) * 1989-08-23 1995-06-27 Biochem Immunosystems, Inc. Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus
AU1749597A (en) * 1996-01-19 1997-08-11 Virginia Mason Research Center Allele-specific peptide epitope strategy for vaccine development
CA2238660A1 (en) * 1998-05-22 1999-11-22 Janet Chantler Gene sequences of rubella virus associated with attenuation
SE9903031D0 (sv) * 1999-08-27 1999-08-27 Eurodiagnostica Ab Peptide mixture and vaccine against a chronic viral infection
DE60229867D1 (de) * 2001-07-02 2008-12-24 Merrion Res Iii Ltd Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen
BRPI0815008B8 (pt) 2007-08-02 2021-05-25 Biondvax Pharmaceuticals Ltd vacinas multiméricas com múltiplos epítopos contra influenza
AU2011360572B2 (en) 2011-02-22 2017-03-02 Biondvax Pharmaceuticals Ltd. Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
AU2014359292B2 (en) * 2013-12-03 2019-02-28 Swiss Tropical And Public Health Institute Proline-rich peptides protective against S. pneumoniae
CN107098980A (zh) * 2017-06-28 2017-08-29 潍坊汉唐生物工程有限公司 一种检测风疹病毒抗体的融合蛋白及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2206587A (en) * 1987-07-08 1989-01-11 London Biotechnology Ltd Rubella e1 glycoprotein antigens
US5164481A (en) * 1989-08-23 1992-11-17 Iaf Biochem International Inc. Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus

Also Published As

Publication number Publication date
CA2128407A1 (en) 1993-07-22
NO942707L (no) 1994-09-20
AU662954B2 (en) 1995-09-21
RU94040393A (ru) 1996-11-10
FI943418A0 (fi) 1994-07-19
GB9201139D0 (en) 1992-03-11
EP0624198A1 (en) 1994-11-17
AU3341393A (en) 1993-08-03
US6037448A (en) 2000-03-14
CA2128407C (en) 2002-04-09
WO1993014206A2 (en) 1993-07-22
JPH07503133A (ja) 1995-04-06
FI943418A (fi) 1994-09-15
WO1993014206A3 (en) 1993-10-28

Similar Documents

Publication Publication Date Title
DE69126606D1 (de) Vakzine
NO976060D0 (no) Vaksiner mot hepatitt C
ATE151627T1 (de) Saugflasche
NO921364D0 (no) Hybridpolypeptid
DK91192D0 (da) Protein
DE69332485D1 (de) Immunmodulierende peptide
FI944052A0 (fi) Oraalinen rokote
NO942707D0 (no) Syntetiske peptider egnet for vaksine mot rubellsinfeksjoner
ATE159226T1 (de) Verpackungssystem
NO941637D0 (no) Sikringsanordning for sammenföyde gjenstander
DE69630611D1 (de) Antigenische präparationen
ITPN920022V0 (it) Imballo riutilizzabile ricompattabile
ITRM920614A1 (it) Proiettore per veicoli
DE69215896D1 (de) Hybrid-flugzeug
BR9301414A (pt) Pneumatico
ITRM910385A1 (it) Vaccini utilizzanti eritrociti come veicoli di antigeni
DK25693D0 (da) Skilleapparat
DE69307100D1 (de) Zwischenspeicher/Stapelvorrichtung
NO932237D0 (no) Lineaere peptider
ITMI911233A1 (it) Dispositivo per la manipolazione di cravatte
IT1240725B (it) Proiettore per veicoli
DE59308065D1 (de) Verpackung
FI925638A0 (fi) Monoklonal antikropp 88bv59 riktad mot en i samband med tumoerer foerekommande antigen
ITMI922675A1 (it) Peptidi immunogenici
NO943251D0 (no) Oral vaksine